Related Experiment Video
Updated: Aug 5, 2026

08:08
Simulator Training for Endovascular Neurosurgery
Published on: May 6, 2020
First multicenter experience with the SOFIA 88 super-large-bore aspiration catheter in mechanical thrombectomy
Sophia Hohenstatt1,2, Răzvan Alexandru Radu3, Anca Negrila3
1Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany sophia.hohenstatt@med.uni-heidelberg.de.
Journal of Neurointerventional Surgery
|July 29, 2026
Summary
The SOFIA 88 catheter demonstrated effective clot engagement and high reperfusion rates in mechanical thrombectomy for large vessel occlusion. This real-world study confirms its feasibility and safety in stroke treatment.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Medical Devices
Background:
- Super-large-bore aspiration catheters aim to enhance clot retrieval during mechanical thrombectomy.
- Clinical performance varies among 0.088-inch platforms, necessitating real-world data.
- The SOFIA 88 catheter's performance in anterior circulation large vessel occlusion was evaluated.
Purpose of the Study:
- To assess the real-world effectiveness and safety of the SOFIA 88 aspiration catheter.
- To evaluate target access, first-pass effect, and reperfusion rates.
- To analyze procedural complications and safety outcomes.
Main Methods:
- Retrospective multicenter European registry of patients undergoing mechanical thrombectomy with SOFIA 88.
- Inclusion criteria: anterior circulation large vessel occlusion (internal carotid artery or M1).
- Primary outcome: successful catheter advancement to thrombus-vessel interface; secondary outcomes: angiographic and safety measures.
Main Results:
- SOFIA 88 achieved target access in 82.7% of cases, often with smaller catheter support.
- First-pass effect was observed in 39.5% of the overall cohort and 47.8% with successful access.
- High rates of final complete (82.7%) and successful (97.5%) reperfusion were achieved with low complication rates (3.7%).
Conclusions:
- SOFIA 88 is feasible for target access and achieves high reperfusion rates in mechanical thrombectomy.
- The device shows favorable standalone first-pass performance and acceptable safety.
- Further studies are needed to optimize patient selection and its role in thrombectomy.
